Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.8M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
2.04M
-
Shares change
-
+608K
-
Total reported value, excl. options
-
$545K
-
Value change
-
-$131K
-
Number of buys
-
14
-
Number of sells
-
-9
-
Price
-
$0.27
Significant Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q2 2025
25 filings reported holding ASBP - Aspire Biopharma Holdings, Inc. - Common Stock as of Q2 2025.
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04M shares
of 48.8M outstanding shares and own 4.19% of the company stock.
Largest 10 shareholders include Procyon Advisors, LLC (648K shares), Crewe Advisors LLC (627K shares), Optivise Advisory Services LLC (235K shares), JANE STREET GROUP, LLC (153K shares), VR Advisory Services Ltd (97.4K shares), Three Seasons Wealth, LLC (75K shares), Periscope Capital Inc. (75K shares), VALLEY WEALTH MANAGERS, INC. (40K shares), Platform Technology Partners (37.6K shares), and GOLDMAN SACHS GROUP INC (18.7K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.